» Authors » Kim Hinshaw

Kim Hinshaw

Explore the profile of Kim Hinshaw including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 321
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Leech C, Nutbeam T, Chu J, Knight M, Hinshaw K, Appleyard T, et al.
Resuscitation . 2024 Dec; 207:110479. PMID: 39736393
Objective: To examine maternal and neonatal outcomes following Resuscitative Hysterotomy for out of hospital cardiac arrest (OHCA) and to compare with timing from cardiac arrest to delivery. Methods: The review...
2.
Brogaard L, Hinshaw K, Kierkegaard O, Manser T, Uldbjerg N, Hvidman L
Front Med (Lausanne) . 2024 Feb; 11:1330443. PMID: 38371513
Introduction: In Northern Europe, vacuum-assisted delivery (VAD) accounts for 6-15% of all deliveries; VAD is considered safe when conducted by adequately trained personnel. However, failed vacuum extraction can be harmful...
3.
Khan R, Hinshaw K
Best Pract Res Clin Obstet Gynaecol . 2022 Mar; 80:67-74. PMID: 35260355
The avoidance of harm is an increasingly important theme in healthcare, and this is particularly the case in women's health. Adverse outcomes in maternity care have a profound impact on...
4.
Devall A, Chu J, Beeson L, Hardy P, Cheed V, Sun Y, et al.
Health Technol Assess . 2021 Nov; 25(68):1-114. PMID: 34821547
Trial Design: A randomised, parallel-group, double-blind, placebo-controlled multicentre study with health economic and nested qualitative studies to determine if mifepristone (Mifegyne, Exelgyn, Paris, France) plus misoprostol is superior to misoprostol...
5.
Hodgetts-Morton V, Hewitt C, Jones L, Leighton L, Pilarski N, Molloy E, et al.
Trials . 2021 Aug; 22(1):529. PMID: 34380528
Background: Cervical cerclage is a recognised treatment to prevent late miscarriage and pre-term birth (PTB). Emergency cervical cerclage (ECC) for cervical dilatation with exposed unruptured membranes is less common and...
6.
Chu J, Devall A, Beeson L, Hardy P, Cheed V, Sun Y, et al.
Lancet . 2020 Aug; 396(10253):770-778. PMID: 32853559
Background: The anti-progesterone drug mifepristone and the prostaglandin misoprostol can be used to treat missed miscarriage. However, it is unclear whether a combination of mifepristone and misoprostol is more effective...
7.
Coomarasamy A, Harb H, Devall A, Cheed V, Roberts T, Goranitis I, et al.
Health Technol Assess . 2020 Jul; 24(33):1-70. PMID: 32609084
Background: Progesterone is essential for a healthy pregnancy. Several small trials have suggested that progesterone therapy may rescue a pregnancy in women with early pregnancy bleeding, which is a symptom...
8.
Coomarasamy A, Devall A, Brosens J, Quenby S, Stephenson M, Sierra S, et al.
Am J Obstet Gynecol . 2020 Feb; 223(2):167-176. PMID: 32008730
Progesterone is essential for the maintenance of pregnancy. Several small trials have suggested that progesterone supplementation may reduce the risk of miscarriage in women with recurrent or threatened miscarriage. Cochrane...
9.
Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Bowler U, et al.
Health Technol Assess . 2019 Oct; 23(54):1-54. PMID: 31590702
Background: Sepsis is a leading cause of direct and indirect maternal death in both the UK and globally. All forms of operative delivery are associated with an increased risk of...
10.
Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Hinshaw K, et al.
Lancet . 2019 May; 393(10189):2395-2403. PMID: 31097213
Background: Risk factors for maternal infection are clearly recognised, including caesarean section and operative vaginal birth. Antibiotic prophylaxis at caesarean section is widely recommended because there is clear systematic review...